
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Department of Surgery, University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky 40202 [H. L. Y., Y. B. D., M. J. E., K. M. M.], and Department of Neuro-Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030 [T. J. L.]
The prognosis for patients with esophageal cancer remains poor, prompting the search for new treatment strategies. Overexpression of E2F-1 has been shown to induce apoptosis in several cancer cell types. In the present study, the effect of adenovirus-mediated E2F-1 overexpression on human esophageal cancer cell lines Yes-4 and Yes-6 was evaluated. Cells were treated by mock infection, infection with an adenoviral vector expressing ß-galactosidase (Ad5CMV-LacZ), or E2F-1 (Ad5CMVE2F-1). Western blot analysis confirmed marked overexpression of E2F-1 in Ad5CMVE2F-1-infected cells. Overexpression of E2F-1 resulted in marked growth inhibition and rapid loss of cell viability due to apoptosis, although Yes-6 cells were somewhat more resistant to E2F-1-mediated growth inhibition than Yes-4 cells. Cell cycle analysis revealed that overexpression of E2F-1 led to G2 arrest, followed by apoptotic cell death. p53 expression remained undetectable in both cell lines after E2F-1 overexpression. The apoptosis inhibitor proteins of the Bcl-2 gene family, Bcl-2, Mcl-1, and Bcl-XL, decreased at 48 h after infection in Yes-4 cells, but remained unchanged in Yes-6 cells. Levels of retinoblastoma gene product (pRb) declined at 48 h after E2F-1 infection in Yes-4 cells, at which apoptosis predominated, whereas pRb expression remained constant in Yes-6 cells. Expression of p14ARF did not change after E2F-1 infection in either cell line. Involvement of caspase 3 and caspase 6 in E2F-1-mediated apoptosis was demonstrated by cleavage of caspase 3/CPP32 and poly-ADP-ribose polymerase, as well as fragmentation of the caspase 6 substrate, lamin B. These results indicate that the sensitivity of esophageal cancer cells to E2F-1-mediated apoptosis may be related to differential expression of Bcl-2 family member proteins and suggest that the adenovirus-mediated E2F-1 gene therapy may be a promising treatment strategy for the treatment of this disease.
This article has been cited by other articles:
![]() |
W.-W. Yang, B. Shu, Y. Zhu, and H.-T. Yang E2F6 Inhibits Cobalt Chloride-Mimetic Hypoxia-induced Apoptosis through E2F1 Mol. Biol. Cell, September 1, 2008; 19(9): 3691 - 3700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Evangelou, A Kotsinas, T Mariolis-Sapsakos, A Giannopoulos, P K Tsantoulis, C Constantinides, T G Troupis, M Salmas, A Kyroudis, C Kittas, et al. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus J. Clin. Pathol., May 1, 2008; 61(5): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Yamazaki, M Hasegawa, I Ohoka, K Hanami, A Asoh, T Nagao, I Sugano, and Y Ishida Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus J. Clin. Pathol., September 1, 2005; 58(9): 904 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, K. Mimori, T. Inageta, Y. Murakumo, A. Vecchione, M. Mori, and Y. Furukawa Components of DNA Damage Checkpoint Pathway Regulate UV Exposure-Dependent Alterations of Gene Expression of FHIT and WWOX at Chromosome Fragile Sites Mol. Cancer Res., March 1, 2005; 3(3): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hershko and D. Ginsberg Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis J. Biol. Chem., March 5, 2004; 279(10): 8627 - 8634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger, A. Pataer, K. Yoshida, Y. Liu, X. Lu, S. G. Swisher, and K. K. Hunt The Mitochondrial Apoptosis-Inducing Factor Plays a Role in E2F-1-Induced Apoptosis in Human Colon Cancer Cells Ann. Surg. Oncol., April 1, 2003; 10(3): 314 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Dong, H. L. Yang, M. J. Elliott, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Sensitizes Melanoma Cells to Apoptosis Induced by Topoisomerase II Inhibitors Cancer Res., March 1, 2002; 62(6): 1776 - 1783. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |